Insomnia Treatment Market Report 2021
Report Code: KNJ848959 No. of Pages: 144 Category: Pharmaceuticals and Healthcare
Publisher: Date of Publish:
Publisher: Date of Publish:
Extract: Based on this comprehensive report published by Gravitas Market Insights, the Insomnia Treatment market is said to witness a significant growth during the forecast years between 2021 and 2028. Insomnia is a sleep disorder in which a person finds it difficult to sleep or stay asleep. Low stamina, daytime sleepiness, depression, and irritability are among the symptoms. It is a very common disorder that affects millions of people all over the world. Circadian rhythm disruption, chronic pain, hyperthyroidism, menopause, psychological stress, and other medical conditions all contribute to insomnia. Furthermore, excessive use of drugs such as caffeine, alcohol, and nicotine may result in insomnia. Report Scope in detail: This latest report edition of Insomnia Treatment market has been added to our huge database of detailed reports and this envisions to shape the future of all the related businesses. Our team of learned research analysts have studied in-depth and curated the report based on several aspects which include the overview of the market, driving forces, growth rate, market trends, market size, opportunities and challenges of the market; along with detailed competitive analysis on the regional as well as global level. The Insomnia Treatment market research report renders a thorough analysis of the market on a global aspect and aims on several market segmentation. This report also provides deeper perception into the latest trends of the market and pinpoints crucial product developments of the industry. Furthermore, the report collects numerous factors that have accredited to the growth of the market in the recent years. Market Dynamics: • The influence of driving factors is expected to outweigh the influence of restraints. Furthermore, technological advancements have resulted in increased adoption, and untapped markets in developing economies are expected to provide new avenues for the growth of the insomnia market in the near future. • As the prevalence of insomnia rises, an increasing number of patients seek pharmacological treatment. • There are currently numerous options in the insomnia treatment market; however, research continues to be on the bandwagon in order to seek newer pharmacological treatments. Insomnia Treatment Market Segmentation: By Drug Type • OTC Sleep Aids • OTC Drugs • OTC Sleep Supplements • Prescription Drugs By Distribution Channel • Retail Pharmacies • Hospital Pharmacies • Drug Stores • e-Commerce • Others Regional Coverage • North America o United States o Canada o Mexico • Europe o UK o Germany o France o Italy o Spain o Russia o Rest of Europe • Asia Pacific o China o India o Japan o Korea o Australia o Southeast Asia o Rest of Asia-Pacific • South America o Brazil o Argentina o Colombia o Rest of South America • Middle East & Africa o GCC o South Africa o Rest of Middle East & Africa Competitive Analysis: Eminent market players have been outlined in order to extract improved insights into the worldwide businesses. Our research reports offer all-inclusive information on various top most manufacturers that are operational across global regions. We provide company profiles which include detailed overview of the company, business information, business performance, crucial strategies implemented through the years. Few of the Key Players Covered in Our Report: • Natrol, LLC • Sanofi SA • Sunovion Pharmaceuticals, Inc. • PERNIX Therapeutics • Pfizer Inc. • Takeda Pharmaceutical Company Limited • Merck & Co. Inc. • GlaxoSmithKline Plc. • Mallinckrodt • Boehringer Ingelheim International GmbH Impact of COVID19: The COVID19 pandemic crippled the global economy, it resulted in a worldwide lockdown and this has majorly impacted numerous industries. Our industry experts are working round-the-clock to identify, accumulate and in-time deliver market analysis due to the effect of unprecedented decisions in COVID-19 repercussions on many businesses. The full version of this report will comprise the overall impact of the pandemic, and predicted alteration on the future outlook of the industry, by taking into the account the economic, political, technological and social parameters.
Section 1: Executive Summary 1.1. Insomnia Treatment Market Industry 360° outline, Year 2016 – 2028 1.2. Business Model Trends 1.3. Growth Trends 1.4. End-User/Distribution Channel Trends 1.5. Regional Trends Section 2: Market Dynamics - Insomnia Treatment Market Industry Insights 2.1. Growth Drivers 2.2. Opportunities 2.3. Industry challenges 2.4. SWOT Analysis 2.5. Porter’s Analysis 2.6. Worldwide Industry Landscape, Year 2016 – 2028 2.7. Industry Segmentation 2.8. Technology & Invention landscape 2.9. Regional Landscape 2.9.1. North America 2.9.2. Europe 2.9.3. Asia-Pacific 2.9.4. South America 2.9.5. Middle East & Africa 2.10. Competitive Environment Section 3: Global Insomnia Treatment Market, By Drug Type 3.1. Segmentation Analysis, By Drug Type, 2016-2028 3.2. Market Share Segmentation Analysis, By Drug Type, 2016-2028 3.3. OTC Sleep Aids 3.3.1. Market estimates and forecast with Growth rate analysis, 2016 – 2028 3.4. OTC Drugs 3.4.1. Market estimates and forecast with Growth rate analysis, 2016 – 2028 3.5. OTC Sleep Supplements 3.5.1. Market estimates and forecast with Growth rate analysis, 2016 – 2028 3.6. Prescription Drugs 3.6.1. Market estimates and forecast with Growth rate analysis, 2016 – 2028 Section 4: Global Insomnia Treatment Market, By Distribution Channel 4.1. Segmentation Analysis, By Distribution Channel, 2016-2028 4.2. Market Share Segmentation Analysis, By Distribution Channel, 2016-2028 4.3. Retail Pharmacies 4.3.1. Market estimates and forecast with Growth rate analysis, 2016 – 2028 4.4. Hospital Pharmacies 4.4.1. Market estimates and forecast with Growth rate analysis, 2016 – 2028 4.5. Drug Stores 4.5.1. Market estimates and forecast with Growth rate analysis, 2016 – 2028 4.6. e-Commerce 4.6.1. Market estimates and forecast with Growth rate analysis, 2016 – 2028 4.7. Others 4.7.1. Market estimates and forecast with Growth rate analysis, 2016 – 2028 Section 5: Global Insomnia Treatment Market, Regional Analysis 5.1. Global Insomnia Treatment Market, Regional Analysis 5.2. North America, Country level Analysis 5.2.1. North America Insomnia Treatment Market estimates and forecast with Growth rate analysis, By Drug Type, 2016 – 2028 5.2.2. North America Insomnia Treatment Market estimates and forecast with Growth rate analysis, By Distribution Channel, 2016 – 2028 5.2.3. United States 5.2.3.1. Market estimates and forecast with Growth rate analysis, 2016 – 2028 5.2.4. Canada 5.2.4.1. Market estimates and forecast with Growth rate analysis, 2016 – 2028 5.2.5. Mexico 5.2.5.1. Market estimates and forecast with Growth rate analysis, 2016 – 2028 5.3. Europe Country level Analysis 5.3.1. Europe Insomnia Treatment Market estimates and forecast with Growth rate analysis, By Drug Type, 2016 – 2028 5.3.2. Europe Insomnia Treatment Market estimates and forecast with Growth rate analysis, By Distribution Channel, 2016 – 2028 5.3.3. UK 5.3.3.1. Market estimates and forecast with Growth rate analysis, 2016 – 2028 5.3.4. Germany 5.3.4.1. Market estimates and forecast with Growth rate analysis, 2016 – 2028 5.3.5. France 5.3.5.1. Market estimates and forecast with Growth rate analysis, 2016 – 2028 5.3.6. Italy 5.3.6.1. Market estimates and forecast with Growth rate analysis, 2016 – 2028 5.3.7. Spain 5.3.7.1. Market estimates and forecast with Growth rate analysis, 2016 – 2028 5.3.8. Russia 5.3.8.1. Market estimates and forecast with Growth rate analysis, 2016 – 2028 5.3.9. Rest of Europe 5.3.9.1. Market estimates and forecast with Growth rate analysis, 2016 – 2028 5.4. Asia-Pacific Country level Analysis 5.4.1. Asia-Pacific Insomnia Treatment Market estimates and forecast with Growth rate analysis, By Drug Type, 2016 – 2028 5.4.2. Asia-Pacific Insomnia Treatment Market estimates and forecast with Growth rate analysis, By Distribution Channel, 2016 – 2028 5.4.3. China 5.4.3.1. Market estimates and forecast with Growth rate analysis, 2016 – 2028 5.4.4. India 5.4.4.1. Market estimates and forecast with Growth rate analysis, 2016 – 2028 5.4.5. Japan 5.4.5.1. Market estimates and forecast with Growth rate analysis, 2016 – 2028 5.4.6. Korea 5.4.6.1. Market estimates and forecast with Growth rate analysis, 2016 – 2028 5.4.7. Australia 5.4.7.1. Market estimates and forecast with Growth rate analysis, 2016 – 2028 5.4.8. Southeast Asia 5.4.8.1. Market estimates and forecast with Growth rate analysis, 2016 – 2028 5.4.9. Rest of Asia-Pacific 5.4.9.1. Market estimates and forecast with Growth rate analysis, 2016 – 2028 5.5. South America Country level Analysis 5.5.1. South America Insomnia Treatment Market estimates and forecast with Growth rate analysis, By Drug Type, 2016 – 2028 5.5.2. South America Insomnia Treatment Market estimates and forecast with Growth rate analysis, By Distribution Channel, 2016 – 2028 5.5.3. Brazil 5.5.3.1. Market estimates and forecast with Growth rate analysis, 2016 – 2028 5.5.4. Argentina 5.5.4.1. Market estimates and forecast with Growth rate analysis, 2016 – 2028 5.5.5. Colombia 5.5.5.1. Market estimates and forecast with Growth rate analysis, 2016 – 2028 5.5.6. Rest of South America 5.5.6.1. Market estimates and forecast with Growth rate analysis, 2016 – 2028 5.6. Middle East & Africa Country level Analysis 5.6.1. MEA Insomnia Treatment Market estimates and forecast with Growth rate analysis, By Drug Type, 2016 – 2028 5.6.2. MEA Insomnia Treatment Market estimates and forecast with Growth rate analysis, By Distribution Channel, 2016 – 2028 5.6.3. GCC 5.6.3.1. Market estimates and forecast with Growth rate analysis, 2016 – 2028 5.6.4. South Africa 5.6.4.1. Market estimates and forecast with Growth rate analysis, 2016 – 2028 5.6.5. Rest of Middle East & Africa 5.6.5.1. Market estimates and forecast with Growth rate analysis, 2016 – 2028 Section 6: Company Profile - Insomnia Treatment Market 6.1. Natrol, LLC 6.1.1. Business Overview 6.1.2. Product & Service Offering 6.1.3. Overall Revenue 6.1.4. Strategic Outlook 6.2. Sanofi SA 6.2.1. Business Overview 6.2.2. Product & Service Offering 6.2.3. Overall Revenue 6.2.4. Strategic Outlook 6.3. Sunovion Pharmaceuticals, Inc. 6.3.1. Business Overview 6.3.2. Product & Service Offering 6.3.3. Overall Revenue 6.3.4. Strategic Outlook 6.4. PERNIX Therapeutics 6.4.1. Business Overview 6.4.2. Product & Service Offering 6.4.3. Overall Revenue 6.4.4. Strategic Outlook 6.5. Pfizer Inc. 6.5.1. Business Overview 6.5.2. Product & Service Offering 6.5.3. Overall Revenue 6.5.4. Strategic Outlook 6.6. Takeda Pharmaceutical Company Limited 6.6.1. Business Overview 6.6.2. Product & Service Offering 6.6.3. Overall Revenue 6.6.4. Strategic Outlook 6.7. Merck & Co. Inc. 6.7.1. Business Overview 6.7.2. Product & Service Offering 6.7.3. Overall Revenue 6.7.4. Strategic Outlook 6.8. GlaxoSmithKline Plc. 6.8.1. Business Overview 6.8.2. Product & Service Offering 6.8.3. Overall Revenue 6.8.4. Strategic Outlook 6.9. Mallinckrodt 6.9.1. Business Overview 6.9.2. Product & Service Offering 6.9.3. Overall Revenue 6.9.4. Strategic Outlook 6.10. Boehringer Ingelheim International GmbH 6.10.1. Business Overview 6.10.2. Product & Service Offering 6.10.3. Overall Revenue 6.10.4. Strategic Outlook *Market size and forecast will be provided from 2016-2028, and forecast period would be 2021-2028 *Details on financial performance and strategic moves and developments may not be captured for unlisted companies *List of companies profiled in this TOC is tentative and may change after detailed analysis
NEED Help?
If you need any help or guidance, please feel free to call us.
USA : +1 (661) 636 6162
INDIA : +91 9325802062
or
Write us on : sales@kandjmarketresearch.com